FDA approves new cholesterol lowering drug

July 24, 2015 9:38 PM

14 4

FDA approves new cholesterol lowering drug

Atlanta (CNN)The FDA approved the new cholesterol lowering drug alirocumab, brand name Praluent, on Friday. The injectable drug, from Regenron and Sanofi, is the first in a new class of drugs called PCSK9 inhibitors.

"The drug works by reducing the number of receptors on the liver that remove LDL cholesterol from the blood. By blocking PCSK9's ability to work, more receptors are available to get rid of LDL cholesterol from the blood and, as a result, lower LDL cholesterol levels," said the FDA.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page